Insider · CIK 0001678292

Holuka Eugene Myron

Reports to the SEC for 2 companies · CRANFORD, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001678292

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Director	AAward	+300K sh	—	—	300,000
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Director	AAward	+300K sh	—	—	300,000
2025-09-19	CTORCITIUS ONCOLOGY, INC.A Award	Director	AAward	+300K sh	—	—	300,000
2024-12-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+125K sh	—	—	125,000
2024-11-07	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)A Award	Director	AAward	+125K sh	—	—	125,000
2024-08-12	CTORCITIUS ONCOLOGY, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+150K sh	—	—	150,000
2024-03-13	CTXRCitius Pharmaceuticals, Inc.F Tax Payment	Director	FTax Payment	−48 sh	$0.75	−$36	2,367
2024-03-13	CTXRCitius Pharmaceuticals, Inc. · Stock Option (Right to Purchase Common Stock)M Exercise/Conversion	Director	MExercise/Conversion	−2,415 sh	—	—	0
2024-03-13	CTXRCitius Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,415 sh	$0.01	+$36.225	2,415
2023-10-10	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+75K sh	—	—	75,000
2022-10-04	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+75K sh	—	—	75,000
2021-10-11	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+75K sh	—	—	75,000
2021-07-22	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+15K sh	—	—	15,000
2021-02-16	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+25K sh	—	—	25,000
2020-10-06	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+35K sh	—	—	35,000
2020-07-07	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+25K sh	—	—	25,000
2019-10-08	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+25K sh	—	—	25,000
2018-09-04	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+15K sh	—	—	15,000
2017-09-15	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+10K sh	—	—	10,000
2016-06-23	CTXRCitius Pharmaceuticals, Inc. · Options to Purchase Common StockA Award	Director	AAward	+200K sh	$0.80	+$160K	200,000

Recent filings

Accepted (ET)
Dec 224/A
Holuka Eugene Myron0001213900-25-124528
SEC(opens sec.gov)
Dec 14/A
Holuka Eugene Myron0001213900-25-116682
SEC(opens sec.gov)
Sep 234
Holuka Eugene Myron0001213900-25-090610
SEC(opens sec.gov)
Dec 164
Holuka Eugene Myron0001213900-24-109305
SEC(opens sec.gov)
Nov 124
Holuka Eugene Myron0001213900-24-096887
SEC(opens sec.gov)
Aug 304
Holuka Eugene Myron0001213900-24-074506
SEC(opens sec.gov)
Aug 164
Holuka Eugene Myron0001213900-24-070240
SEC(opens sec.gov)
Oct 124
Holuka Eugene Myron0001013762-23-003532
SEC(opens sec.gov)
Oct 64
Holuka Eugene Myron0001213900-22-062476
SEC(opens sec.gov)
Oct 134
Holuka Eugene Myron0001213900-21-052673
SEC(opens sec.gov)
Jul 264
Holuka Eugene Myron0001213900-21-038692
SEC(opens sec.gov)
Feb 184
Holuka Eugene Myron0001213900-21-010318
SEC(opens sec.gov)
Oct 94
Holuka Eugene Myron0001213900-20-030790
SEC(opens sec.gov)
Jul 94
Holuka Eugene Myron0001213900-20-017086
SEC(opens sec.gov)
Oct 104
Holuka Eugene Myron0001213900-19-020117
SEC(opens sec.gov)
Sep 64
Holuka Eugene Myron0001213900-18-012195
SEC(opens sec.gov)
Sep 194
Holuka Eugene Myron0001477932-17-004606
SEC(opens sec.gov)
Jun 294
Citius Pharmaceuticals, Inc.0001477932-16-011103
SEC(opens sec.gov)

Companies

Address

C/O CITIUS ONCOLOGY, INC. 11 COMMERCE DRIVE, 1ST FLOOR

CRANFORD, NJ, 07016